IN2014DN08294A - - Google Patents

Info

Publication number
IN2014DN08294A
IN2014DN08294A IN8294DEN2014A IN2014DN08294A IN 2014DN08294 A IN2014DN08294 A IN 2014DN08294A IN 8294DEN2014 A IN8294DEN2014 A IN 8294DEN2014A IN 2014DN08294 A IN2014DN08294 A IN 2014DN08294A
Authority
IN
India
Prior art keywords
iron
iron deficiency
prophylaxis
iii
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Thomas Bark
Wilm Buhr
Susanna Burckhardt
Michael Burgert
Camillo Canclini
Franz Dürrenberger
Felix Funk
Peter Otto Geisser
Aris Kalogerakis
Simona Mayer
Erik Philipp
Stefan Reim
Diana Sieber
Jörg Schmitt
Katrin Schwarz
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of IN2014DN08294A publication Critical patent/IN2014DN08294A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN8294DEN2014 2012-04-05 2013-04-04 IN2014DN08294A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12163308 2012-04-05
PCT/EP2013/057071 WO2013150087A1 (de) 2012-04-05 2013-04-04 Fe (iii) - pyrazin - komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien

Publications (1)

Publication Number Publication Date
IN2014DN08294A true IN2014DN08294A (ro) 2015-05-15

Family

ID=48045554

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8294DEN2014 IN2014DN08294A (ro) 2012-04-05 2013-04-04

Country Status (12)

Country Link
US (1) US9439910B2 (ro)
EP (1) EP2833890B1 (ro)
JP (1) JP2015512436A (ro)
KR (1) KR20140143832A (ro)
CN (1) CN104203245A (ro)
AU (1) AU2013244955A1 (ro)
CA (1) CA2864577A1 (ro)
ES (1) ES2623300T3 (ro)
IN (1) IN2014DN08294A (ro)
MX (1) MX2014011886A (ro)
RU (1) RU2014144404A (ro)
WO (1) WO2013150087A1 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111714470B (zh) * 2020-05-27 2022-04-08 天津瑞益瑞美生物技术有限公司 一种兽用肠溶乙二胺四乙酸铁钠预混剂及其制备方法
WO2023244831A1 (en) * 2022-06-17 2023-12-21 Regents Of The University Of Minnesota Iron complexes and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2015512436A (ja) 2015-04-27
EP2833890B1 (de) 2017-02-01
RU2014144404A (ru) 2016-05-27
WO2013150087A1 (de) 2013-10-10
CA2864577A1 (en) 2013-10-05
ES2623300T3 (es) 2017-07-10
EP2833890A1 (de) 2015-02-11
CN104203245A (zh) 2014-12-10
US9439910B2 (en) 2016-09-13
AU2013244955A1 (en) 2014-10-23
KR20140143832A (ko) 2014-12-17
MX2014011886A (es) 2014-11-12
US20150119374A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
PH12019502809A1 (en) Substituted tricyclic compounds as fgfr inhibitors
TN2015000278A1 (en) Autotaxin inhibitors
PH12015500825B1 (en) Substituted benzene compounds
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MX2015006152A (es) Compuestos de aminopirimidina como inhibidores de mutantes de egfr que contienen t7 9 0m.
IN2014MN02049A (ro)
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
GEP20186899B (en) 6 - alkynyl pyridines as smac mimetics
MX2015011193A (es) Compuestos antivirales.
TN2012000457A1 (en) Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
MX2014015884A (es) Compuestos antivirales.
MY171802A (en) Compositions comprising vortioxetine and donepezil
MX2015011198A (es) Compuestos antivirales.
IN2015DN00950A (ro)
MX2015009176A (es) Derivados de triazola antivirales.
IN2015DN02109A (ro)
IN2014DN08294A (ro)
MX2015010892A (es) Compuestos antivirales.
TN2013000379A1 (en) Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
MX2015007974A (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro.
IN2013MU03317A (ro)
MX2015013736A (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro.
MX2015011126A (es) Compuestos antivirales.
MX2015011125A (es) Compuestos antivirales.